| Product Code: ETC8977903 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Romania Parkinsons Disease Market Overview |
3.1 Romania Country Macro Economic Indicators |
3.2 Romania Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Romania Parkinsons Disease Market - Industry Life Cycle |
3.4 Romania Parkinsons Disease Market - Porter's Five Forces |
3.5 Romania Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Romania Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Romania Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Romania Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Romania Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Romania Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of Parkinson's disease in Romania |
4.2.2 Rising geriatric population in Romania leading to higher prevalence of Parkinson's disease |
4.2.3 Implementation of government initiatives and policies supporting Parkinson's disease management and treatment |
4.3 Market Restraints |
4.3.1 Limited access to advanced treatment options and therapies for Parkinson's disease in Romania |
4.3.2 High cost associated with Parkinson's disease medications and therapies in Romania |
4.3.3 Lack of specialized healthcare professionals with expertise in Parkinson's disease management |
5 Romania Parkinsons Disease Market Trends |
6 Romania Parkinsons Disease Market, By Types |
6.1 Romania Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Romania Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Romania Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Romania Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Romania Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Romania Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Romania Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Romania Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Romania Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Romania Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Romania Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Romania Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Romania Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Romania Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Romania Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Romania Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Romania Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Romania Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Romania Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Romania Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Romania Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Romania Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Romania Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Romania Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Romania Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Romania Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Romania Parkinsons Disease Market Export to Major Countries |
7.2 Romania Parkinsons Disease Market Imports from Major Countries |
8 Romania Parkinsons Disease Market Key Performance Indicators |
8.1 Number of Parkinson's disease awareness campaigns conducted annually in Romania |
8.2 Percentage increase in the diagnosis rate of Parkinson's disease patients in Romania |
8.3 Number of government-funded programs or initiatives focused on Parkinson's disease management in Romania |
9 Romania Parkinsons Disease Market - Opportunity Assessment |
9.1 Romania Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Romania Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Romania Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Romania Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Romania Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Romania Parkinsons Disease Market - Competitive Landscape |
10.1 Romania Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Romania Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here